The global Parkinson’s disease drug market is anticipated to grow at a CAGR of over 6% during the forecast period. There's no specific cure available for Parkinson's disease till now. However, various treatments, supportive therapies, such as physiotherapy, surgery, and drugs are available currently. This expected to support the growth of Parkinson’s disease drug market. Moreover, the additional drugs that provide some relief from the symptoms of Parkinson’s disease to maintain the patient’s quality of life will also drive the Parkinson’s disease drug industry.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/parkinsons-disease-drug-market
Moreover, various research is also going on to find the exact cure for Parkinson’s disease which will significantly drive the Parkinson’s disease drug market. For instance, carbidopa-levodopa is the most effective drug used in Parkinson’s disease for the treatment of symptoms of Parkinson’s. However, as the disease progresses, the drugs starting to wear off in between doses.The symptoms of Parkinson’s disease come back or even cause excessive involuntary movements and the condition becomes more challenging to treat. This presents a major setback for the Parkinson’s disease drug market.

A Full Report of Global Parkinson’s Disease Drug Marketis Available at:https://www.omrglobal.com/industry-reports/parkinsons-disease-drug-market

To minimize the side effects of carbidopa-levodopa, the drug dosage is either adjust or use advanced therapies such as a combination of medications, or in some cases,deep brain stimulation is used. This expected to keep up Parkinson’s disease drug industry.However, all patients didn’t agree on deep brain stimulation or brain surgery. Therefore, UCMA has a device called Duopa pump that delivers medicine consistently throughout the day.

The duopa pump was FDA approved in 2015 and it is recently getting popular foruse. Duopa is carbidopa-levodopa in a gel form. Itis constantly administered to the patient using a small infusion pump that delivers the medication slowly all day long. The use of such devices prevents the body from receiving large doses of drugs at once, as it would if it were taken by mouth. Hence, the use of devices such as dopa pump is anticipated to drive the Parkinson’s disease drug market during the forecast period.

Parkinson’s disease is an incurable disorder that has proved various challenges in the process to manage and treat with the available drugs. Hence, disease symptom modification is the ultimate goal for the drug development of Parkinson's which is driving the market growth.

Global Parkinson’s Disease Drug Market- Segmentation
By Drug Class
• Dopamine Receptor Agonists
• MAO-Inhibitors
• Carbidopa-Levodopa
• Catechol O-methyltransferase (COMT) Inhibitors
• Anticholinergics
• Others
•
Global Parkinson’s Disease Drug Market-Segment by Region
North America
• US
• Canada
•
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
•
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
•
Rest of the World
• Latin America
• Middle East Africa
•
Company Profiles
• AbbVie Inc.
• ACADIA Pharmaceuticals Inc.
• Apotex Inc.
• Axovant Gene Therapies Ltd.
• Boehringer Ingelheim GmbH
• Bausch Health Companies Inc.
• Boston Scientific Corp.
• Cipla Inc.
• Daiichi Sankyo Espha Co., Ltd.
• Eli Lilly & Co.
• Eisai Co., Ltd.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline Plc
• Impax Laboratories, Inc.
• Merck & Co. Inc.
• Mylan NV
• Novartis International AG
• Orion Corp.
•
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/parkinsons-disease-drug-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404